Healthcare Equipment and Supplies
Company Overview of Autonomic Technologies, Inc.
Autonomic Technologies, Inc., a medical device company, develops medical implants. Its products include miniaturized implantable neurostimulation devices that provide rapid relief from the debilitating pain and suffering caused by severe headaches. The company was founded in 2007 and is based in Redwood City, California.
3698 Haven Avenue
Redwood City, CA 94063
Founded in 2007
Key Executives for Autonomic Technologies, Inc.
Chief Executive Officer, President and Director
Chief Scientist and Vice President of Research
Chief Commercialization Officer
Compensation as of Fiscal Year 2015.
Autonomic Technologies, Inc. Key Developments
Autonomic Technologies, Inc. Appoints Karl Schweitzer as New Chief Commercialization Officer
Apr 28 14
Autonomic Technologies, Inc. (ATI) announced the appointment of Karl Schweitzer to the position of Chief Commercialization Officer. In this new role, Mr. Schweitzer will lead the company's global sales and marketing efforts, bringing innovative therapies to physicians and their patients who suffer from severe and disabling headaches. Mr. Schweitzer has more than 25 years experience in the field of medical devices. For the past nine years, Mr. Schweitzer was Vice President at Medtronic. Most recently he was Member of the Global Leadership Team of the company's neuromodulation business.
Autonomic Technologies, Inc. Presents at 9th Annual The Neurotech Investing & Partnering Conference 2014, Apr-24-2014 03:30 PM
Mar 20 14
Autonomic Technologies, Inc. Presents at 9th Annual The Neurotech Investing & Partnering Conference 2014, Apr-24-2014 03:30 PM. Venue: The Ritz Carlton, 10 Avery St., Boston, Massachusetts, United States. Speakers: Benjamin D. Pless, Chief Executive Officer, President and Director.
Autonomic Technologies, Inc. Appoints Shashidhar Kori as New Chief Medical Officer
Jan 20 14
Autonomic Technologies, Inc. announced the appointment of Dr. Shashidhar Kori, M.D. to the position of Chief Medical Officer. Dr. Kori has more than 30 years experience in the field of neurosciences. Most recently, Dr. Kori was Vice President of Clinical Development and Medical Affairs at Allergan and MAP Pharmaceuticals. Previously he was Senior Director of Clinical Development and Senior Medical Advisor on the Pain/Migraine Team at GlaxoSmithKline. In these leadership roles, Dr. Kori led the design and execution of numerous clinical studies to support product development and commercialization, built and oversaw an active publication strategy, created a new medical affairs department, served as liaison to the external scientific and medical community, and had significant involvement in new product development and discussions with global regulatory authorities. In his new role, Dr. Kori is responsible for clinical research, clinical outcomes, and regulatory submissions. He will oversee development and execution of all clinical research, including clinical trials of the ATI(TM) Neurostimulation System for cluster headache and migraine in the United States and in Europe. He will also lead interactions with regulatory authorities.
Similar Private Companies By Industry
Recent Private Companies Transactions
May 11, 2015